Role of Early Versus Late Switch to Lapatinib-Capecitabine (TYCO)

NCT01160094 · clinicaltrials.gov ↗
COMPLETED
Status
288
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis